Investment Thesis
Airsculpt is unprofitable with negative operating income and net margins of -4.6% and -6.1% respectively, coupled with critical liquidity constraints evidenced by a 0.75x current ratio. While positive free cash flow of $5.2M shows underlying operational cash generation, the company cannot cover interest expenses from operations (-1.2x interest coverage) and requires immediate path to profitability or working capital restructuring to sustain operations.
Strengths
- Positive operating cash flow of $5.3M and free cash flow of $5.2M despite net losses indicates genuine operational cash generation
- Moderate leverage with 0.45x debt-to-equity ratio avoiding extreme financial distress
- Established $39.4M revenue base in specialized medical aesthetics sector with demonstrated market presence
Risks
- Persistent unprofitability with negative operating margin (-4.6%) and net margin (-6.1%) consuming shareholder value
- Liquidity crisis with current ratio of 0.75x, indicating current liabilities exceed current assets by ~$13M creating refinancing pressure
- Negative interest coverage ratio (-1.2x) means operating income cannot service debt obligations; dependent entirely on cash flow reserves
Key Metrics to Watch
- Operating margin trajectory toward positive territory and timeline to EBITDA profitability
- Current ratio improvement and working capital management to resolve liquidity deficit
- Sustainability of $5.3M operating cash flow and ability to convert to net income profitability
Financial Metrics
Revenue
39.4M
Net Income
-2.4M
EPS (Diluted)
$-0.03
Free Cash Flow
5.2M
Total Assets
192.0M
Cash
16.7M
Profitability Ratios
Gross Margin
N/A
Operating Margin
-4.6%
Net Margin
-6.1%
ROE
-2.4%
ROA
-1.2%
FCF Margin
13.3%
Balance Sheet & Liquidity
Current Ratio
0.75x
Quick Ratio
0.75x
Debt/Equity
0.45x
Debt/Assets
47.8%
Interest Coverage
-1.18x
Long-term Debt
44.8M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-09T07:53:36.298874 |
Data as of: 2026-03-31 |
Powered by Claude AI